|
HS Code |
340375 |
| Chemical Name | 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride |
| Molecular Formula | C6H8BrClN2S |
| Molecular Weight | 255.56 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Solubility | Soluble in water and DMSO |
| Storage Temperature | 2-8°C |
| Smiles | Brc1nc2CCNCC2sc1.Cl |
| Synonyms | 2-Bromo-4,5,6,7-tetrahydrothiazolopyridine hydrochloride |
| Hazard Statements | May cause skin, eye and respiratory irritation |
| Application | Pharmaceutical intermediate, chemical research |
As an accredited 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 5 grams of 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride, tightly sealed, labeled with hazard information. |
| Container Loading (20′ FCL) | 20′ FCL loads 12–14 metric tons of 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride in securely sealed drums. |
| Shipping | **Shipping Description:** 2-Bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride is shipped in sealed, chemically resistant containers, protected from moisture and light. The package is labeled according to applicable regulations, with documentation for safe handling and storage. Shipping complies with all hazardous material guidelines and may require temperature control depending on stability data. |
| Storage | 2-Bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride should be stored in a tightly sealed container, protected from light and moisture. Keep it at room temperature (20–25°C) in a dry, well-ventilated area away from incompatible substances such as strong bases and oxidizers. Ensure clear labeling and restrict access to trained personnel only. Avoid prolonged exposure to air. |
| Shelf Life | 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride is stable for 2 years when stored dry, sealed, and protected from light. |
|
Purity 98%: 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride with 98% purity is used in pharmaceutical intermediate synthesis, where high purity ensures reliable reaction yields. Melting Point 220°C: 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride with a melting point of 220°C is used in solid-state formulation development, where thermal stability enhances compound integrity during processing. Molecular Weight 271.59 g/mol: 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride of 271.59 g/mol is used in structure-activity relationship studies, where accurate molecular weight supports precise dosing calculations. Particle Size <10 μm: 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride with particle size under 10 μm is used in suspension formulation, where small particle size improves dispersion and bioavailability. Solubility 50 mg/mL (water): 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride with solubility of 50 mg/mL in water is used in aqueous drug delivery systems, where high solubility promotes efficient drug release. Stability Temperature 40°C: 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride stable up to 40°C is used in long-term storage applications, where thermal resistance preserves compound efficacy. HPLC Assay ≥ 99%: 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride with HPLC assay not less than 99% is used in analytical reference standards, where high assay accuracy supports validation protocols. |
Competitive 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Working day in and day out with specialty heterocyclic compounds, we continuously see the value that carefully designed molecules deliver to pharmaceutical research, advanced materials, and chemical synthesis. Among the structures that have emerged as key intermediates in medicinal chemistry, 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride holds a unique spot on our factory floor and in countless reaction trials. Our production focus sharpens on this compound for a good reason: reliable, consistently pure intermediates give both scale-up and discovery phases a firm foundation.
Our team produces this compound using a precise bromination approach that controls side-product formation at every stage. Batches come off the line as a free-flowing crystalline solid, specifically designed to integrate smoothly into researchers’ current workflows. Chemists in our plant run daily checks on each batch, tracking the melting point and tracing every impurity with state-of-the-art analytics, so every delivery matches the strictest requirements of progressive synthesis projects. Specifications lean toward high purity, with our regular shipments showing figures above 98%, and water content kept below measurable thresholds that could interfere with subsequent transformations. These choices draw on the push and pull between throughput and reproducibility that we manage every day.
It’s one thing to see such details on a specification page. It’s quite another to watch the reaction vessels, take readings in the control lab, and field direct calls from customers optimizing their synthetic routes. The reality is that trace impurities, inconsistent flow properties, or even micro-variations in salt formation can stall projects or shift outcomes. For this reason, our operation goes beyond the numbers: each batch is the result of hands-on adjustments, a clear reaction roadmap, and operator vigilance, not just equipment.
This hydrochloride salt version offers several advantages over free base or other salt forms in bench and pilot-scale preparations. Over years in the reactor bays and packaging rooms, we’ve seen the hydrochloride settle out in a stable crystalline state, which means shelf life is far less of a concern during bulk storage. Its solid state reduces the risk of volatility found with some amines or inconsistent salting-in found with certain neutral heterocycles. That stability matters—no loss in active content, no mysterious tackiness, no trouble with caking through variable climates in warehousing.
Our partners—whether they design kinase inhibitors, CNS actives, or explore custom building blocks for new libraries—tell us that this compound fits into their alkylation and cross-coupling protocols with little adaptation. The bromine substituent provides a launchpad for Suzuki or Buchwald–Hartwig couplings. More importantly, consistent behavior in their assays traces directly to our controlled handling, lot-to-lot documentation, and expert in-process monitoring of every batch. Production staff, knowing how research timelines can hinge on that next delivery, keep channels open for feedback and adjustment.
Petrochemical-derived starting points and high-yielding routes mean lower cost per kilo, but users care much more about batch uniformity and reaction confidence than the price tag alone. We’ve run direct analyses with both the free base and several rare earth metal analogues aimed at diversifying scaffolds for ligands. The hydrochloride salt demonstrates better handling characteristics, particularly under moisture swing conditions that arise from seasonal shifts. We have watched researchers try to work with some less-stable counterparts—loss of material, pH drift in solution, extra filtration steps to chase after suspended particles. Choosing the hydrochloride over other salt options, for most practical purposes, eliminates these common headaches.
One specific case stands out from three years ago: a global pharma client switched to our hydrochloride option after repeated issues glassing and vacuum-drying intermediate batches made from the free base. Their yield stabilized, handling improved, and downstream isolation in their scale-up plant became both more predictable and less labor-intensive. Stories like this highlight why incremental changes in intermediate formats, after the grind of development, hold major benefits once projects commit to kilogram or ton-scale pursuits.
Our team depends on more than batch testing or basic assays. Lab techs and production chemists work shoulder-to-shoulder with QA to capture every outlier, log each deviation and, above all, listen closely to feedback from the bench scientists who depend on our materials. Over time, we’ve learned that even minor shifts—say, a half-percent bump in moisture or an overlooked fine particle—can ripple through a synthesis cascade. Our process prioritizes robust drying protocols and material transfer systems that prevent contamination or hydrolysis, based not only on established best practices but on dozens of pilot runs where such details fully revealed themselves.
Reflecting on our experience, success comes from more than raw measurements. It emerges from a culture of visibility—transparency in batch records, traceability back to starting raw materials, and a practical approach to modifying in-process controls when something feels off. For example, in 2021, a subtle drift in bromine peak on the HPLC led the team to uncover a new byproduct phase, prompting an adjustment in quenching and filtration steps that became part of our long-term protocol.
Manufacturing specialty thiazolopyridine derivatives involves more than just technical process control. We emphasize closed-system handling of raw brominating agents for worker safety and point-source extraction for any volatile components. Every upgrade is born out of feedback from shopfloor operators who see up close where risk points lurk, not just what textbooks predict. In terms of environmental responsibility, our plant has moved toward lower-residue solvents and scalable recycling of wash streams. These changes not only meet regulatory requirements but reflect ongoing respect for both our neighbors and the global community.
Daily safety briefings, clear signage on storage vessels, mandatory PPE, and routine exposure testing set the tone. Staff join review sessions every quarter to share real incidents—such as a near-miss with reactive waste in a holding tank or equipment maintenance that uncovered a small leak in the nitrogen-purge line. We’ve seen these small events drive bigger improvements in response. These routine practices keep both product and people safe—from the reactor to the final shipment.
Early methods for this kind of heterocycle focused on milligram-scale research, often in academic labs. Once requests escalated to pilot and then production-scale, subtle issues in filtration, drying, and yield reproducibility surfaced. In large-scale vessels, even simple adjustments—such as swapping drying gases or altering filtration mesh sizes—showed surprising impact on crystal properties and final appearance. Our staff learned the importance of real-world pilot runs before any commitment to full production, seeing how bulk and fine powder forms settle or compact differently under varied humidity or air flow in the packing lines.
Investment in in-line monitoring gives us more than compliance tick-boxes; it flags problems before they cascade. For instance, continuous NIR probes pick up potential hydrate formation that otherwise might slip past traditional sampling. This lets us catch out-of-spec production early, saving time and waste. Walking the packing room, catching stray dust, and checking the tightness of sealed bags—small habits borne out of lessons from years in manufacturing—make all the difference once these molecules leave our plant for cutting-edge pharmaceutical research.
Some of our most useful collaborations come after the truck has left and the material is in the hands of research chemists hitting stumbling blocks in their process. In one notable example, a development team found inconsistent conversion to a key arylated intermediate. Our technical support reviewed freeze-thaw cycle data and offered adjusted handling steps, including temperature and humidity considerations for the hydrochloride salt. Their conversion rate improved by ten percent over the next batch series.
We believe in closing the loop between factory and end-user lab. Concrete case studies from partners feed future process improvements and documentation updates, with training rolled out to line workers and technical staff who may never see the customer’s facility but share in these advances. Our technical hotline doesn't just serve as trouble-shooting; it’s a feedback engine driving next iterations on drying, sampling, and batch tracking.
Innovation in drug discovery and material science depends on the reliability of supply chain partners. We stand behind this compound as more than just another line item. Transparency, traceability, and technical engagement matter as much as price or throughput. Key opinion leaders in heterocyclic chemistry stress that the path from small-molecule scaffold to final API relies on confidence in every step, especially at the intermediate level. We see firsthand how reliable performance in pilot batches reduces troubleshooting and accelerates project milestones.
We’ve participated in collaborative projects with university R&D teams, multinational pharma, and specialty CROs, where supply consistency and rapid troubleshooting outpace most abstract metric of “purity on paper.” Our willingness to send technical staff onsite, offer custom documentation, or roll out non-standard packaging options sometimes matters more than tweaks in yield or marginal differences in assay results.
Reactive intermediates tend to challenge operators not just during synthesis, but at every stage including crystallization, filtration, and storage. We’ve refined our own approach to 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride production based on data from dozens of iteration cycles. In practice, early phase process development will show crisp yields, yet minor scaling up—say from 10 grams to 500 grams—exposes new bottlenecks in washing or crystallization. Our core technical group keeps records on solvent volumes, filter clogging rates, and drying curves to identify small but crucial improvements.
One major breakthrough involved shift to an alternative solvent mix for the final precipitation step, producing a finer, more free-flowing crystalline salt. This change reduced downtime in our packing line by a third and improved the ease of subsampling during quality testing. Long-term, these process innovations cycle back into raw economic benefit for customers and smoother daily routine for the production shifts here at the plant.
Years of firsthand experience, batch tracking, and technical exchanges with partners give us a clear view of how this intermediate stacks up to alternatives. Some compounds with closely related frameworks show higher baseline reactivity, but often at the expense of storage stability or reproducible crystallization. By focusing on the hydrochloride salt, we sidestep the hydrolysis and atmospheric degradation risks found in many free base analogues or some plateauing performance seen in nitrate or sulfate forms. Real process data, from both our plant and customer outcomes, make the case.
End users often ask whether paying a premium for specialized forms translates to smoother chemistry. We answer from years of servicing repeat orders and field support calls: operational consistency makes a bigger impact than one-off price swings or headline assay purity. For us, communicating both the “how” and “why” behind our process helps customers gain confidence not only in each delivery but in their own project deadlines.
Supply chains during the past decade have faced disruptions from everything like raw material shortages, supply embargoes, and pandemic slowdowns. Our investment in backward integration (direct sourcing and vertical control over ledgered materials) ensures our partners experience less downtime and a more transparent chain of custody from first raw input to finished intermediate. We welcomed regulatory and customer audits alike—not only to prove compliance, but to share practical knowledge captured in our own improvement logs and standard operating procedures.
Applauding the breakthroughs made possible by researchers who rely on specialty hydrochloride salts, we keep our doors open to feedback, on-site technical visits, and collaborative troubleshooting. Production chemists and R&D partners share a rare, ground-level perspective that transcends data sheets and marketing copy; they work together to make each batch just a little better than the last.
Chemical manufacturing, particularly with advanced heterocycles, never turns entirely routine; every production run brings new challenges and learning opportunities. Our continued focus on robust conditions, prompt support, and honest feedback loops keeps these specialty salts—like 2-bromo-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine hydrochloride—at the cutting edge of what’s possible in chemical research and production. Each improvement reflects not only intention but deep respect for the process, the people behind the glass, and those relying on our work to push chemistry forward.